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Correction to “3-Fluoro-4-hydroxyprolines: Synthesis,
Conformational Analysis, and Stereoselective Recognition by the
VHL E3 Ubiquitin Ligase for Targeted Protein Degradation”
Andrea Testa, Xavier Lucas, Guilherme V. Castro, Kwok-Ho Chan, Jane E. Wright, Andrew C. Runcie,
Morgan S. Gadd, William T. A. Harrison, Eun-Jung Ko, Daniel Fletcher, and Alessio Ciulli*
J. Am. Chem. Soc. 2018, 140 (29), pp 9299−9313; DOI: 10.1021/jacs.8b05807.
*S Supporting Information
Page 9302 (bottom of left column) and Supporting Information
(page S10). The concentration of the silyl enol ether 2 was
incorrectly quoted as 0.67 M. The correct ﬁgure is 0.067 M as
follows. The complete corrected Supporting Information is
available.
“Under optimized conditions, the silyl enol ether 2 and
Selectﬂuor were dissolved in anhydrous acetonitrile (0.067 and
0.1M, respectively) and pumped at a rate of 0.77mL/min in a 10
mL ﬂow reactor”
Page 9310, Figure 7D. It has come to our attention that two
values of compound concentrations in the horizontal axis of
Figure 7D were not correct. The data analysis and conclusions
are not aﬀected by this transcription error. The ﬁgure with the
corrected values of concentrations in panel D is shown below.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/jacs.9b03833.
Supplementary results (Tables S1−S6 and Figures S1−
S5); materials and methods section; supplementary
references; crystal structures have been deposited in the
PDB with accession codes 6GFX, 6GFY, and 6GFZ for
VBC in complex with compounds 13a, 14a, and 14b,
respectively; data collection and reﬁnement statistics;
representative ITC titrations; NMR spectra of key
intermediates and ﬁnal compounds (PDF)
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Figure 7.BET protein degradation induced by F-Hyp-containing PROTACs. (A) Chemical structure of PROTACs 15a,b. (B)HeLa cells were treated
with 15a or 15b and vehicle control (0.01% DMSO) for 24 h. Abundance of individual BET protein was analyzed by Western blotting using
corresponding speciﬁc antibodies after SDS-PAGE. (C)Antiproliferative activity of compounds 15a,b,MZ1, and inactive epimer cisMZ1.MV4;11 cells
were treated with compounds for 72 h prior to quantitation of cell proliferation using the CellTiter-Glo luminescent cell viability assay. The relative
signal reﬂects luminescence values normalized to DMSO control. (D) A549 cells stained with crystal violet dye, following a 7-day incubation with
compounds 15a,b, MZ1, and inactive epimer cisMZ1. Dark background was added to improve legibility.
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